Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer - Poll - MDSpire

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

  • By

  • Zhoujunyi Tian

  • Haoshuai Yang

  • Jin Zhang

  • Qiduo Yu

  • Deruo Liu

  • Meng Yang

  • Zhenrong Zhang

  • Chaoyang Liang

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

  • by Zhoujunyi Tian, Haoshuai Yang, Jin Zhang, Qiduo Yu, Deruo Liu, Meng Yang, Zhenrong Zhang, Chaoyang Liang

  • May 28, 2026

Related Content

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

From molecular networks to translational intervention: current progress in the mechanisms of gemcitabine resistance in bladder cancer

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge